Publications by authors named "Jonathan Barker"

Claim this Profile
P
Prevalence of comorbidity amongst people with palmoplantar pustulosis: A systematic review and meta-analysis.
David Gleeson, Mark Corbett, Shern P Choy, Treasa Jiang, John Y W Lee, Jonathan N Barker

J Eur Acad Dermatol Venereol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical phenotype of 504 pustular psoriasis patients from Europe and Egypt: a multi-center observational study.
Alshimaa Mostafa, Ahmed Arafa, Yasser Gohary, Florian Anzengruber, Mohamed El-Komy, Jonathan Barker

Clin Exp Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic liability to psoriasis predicts severe disease outcomes.
Jake R Saklatvala, Samuel Lessard, Maris Teder-Laving, Laurent F Thomas, Ravi Ramessur, Jonathan N Barker

Genome Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol Pathway Gene Variants and Reduced Keratinocyte Cholesterol Support a Final Common Druggable Pathway in Hyperproliferative Inflammatory Skin Diseases.
Melissa Riachi, Dale Bryant, James Ellis, Connor Hughes, Satyamaanasa Polubothu, Jonathan Barker

J Invest Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the Genetic Basis of the Influence of Adiposity on Psoriasis: A Cross-Sectional Study in a Large United Kingdom Population-Based Biobank.
Ravi Ramessur, Jake Saklatvala, Mari Løset, Laurent F Thomas, Ashley Budu-Aggrey, Jonathan N Barker

J Invest Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking on palmoplantar pustulosis.
Alice Smail, Nick Dand, Xinyue Liu, , David Baudry, Jonathan N Barker

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasis.
Weiyu Ye, Kingsley Powell, Niamh Dooley, Charlotte M Thomas, Bola Coker, Jonathan N Barker

BMJ Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study.
Weiyu Ye, Niamh Dooley, Wei Ren Tan, Bolaji Coker, Teresa Tsakok, Jonathan N Barker

J Eur Acad Dermatol Venereol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalizing Biologic Therapy in Psoriasis: Development, Validation, and User Testing of a Precision-Dosing Dashboard.
Charlotte M Thomas, David Baudry, Zehra Arkir, Bola Coker, Tejus Dasandi, Jonathan Barker

J Invest Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Risk Factors in Childhood Psoriasis.
Christopher Willy Schwarz, Christoffer Blegvad, David Baudry, Isabella Tosi, Sang-Hyuck Lee, Jonathan N Barker

J Invest Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares.
James G Krueger, Mrinal K Sarkar, Mark G Lebwohl, Akimichi Morita, Kenneth Gordon, Jonathan N Barker

J Clin Invest· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association meta-regression identifies stem cell lineage orchestration as a key driver of acne risk.
Jessye Maxwell, Brittany L Mitchell, Xinyi Du-Harpur, Luba M Pardo, Willemijn C A M Witkam, Jonathan N Barker

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.
David Gleeson, Sarah Chapman, Helen McAteer, April Qin, John Gregory, Jonathan Barker

BMJ Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Apremilast Over 52 Weeks in Patients with Plaque Psoriasis in High-Impact Areas and Impaired Quality of Life.
Matthias Augustin, Jonathan Barker, Curdin Conrad, Denis Jullien, Jose-Manuel Carrascosa

Dermatol Ther (Heidelb)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The polygenic architecture of hidradenitis suppurativa reveals signaling mechanisms that implicate epithelial remodeling.
Atlas Khan, Poppy A Gould, Yiming Luo, Errol P Prens, Lee Wheless, Jonathan Barker

medRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GWAS Meta-Analysis Identifies Susceptibility Loci for Keloids and Hypertrophic Scarring in Europeans.
Nick Dand, Chuin Y Ung, Jake R Saklatvala, Michael A Simpson, Jonathan N Barker

J Invest Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of spesolimab on sustained disease control in patients with generalized pustular psoriasis: Post hoc analysis of the EFFISAYIL 2 study.
Kenneth B Gordon, Matthias Augustin, Jonathan Barker, Yayoi Tada, Mark G Lebwohl

J Am Acad Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions.
Kenneth B Gordon, Yayoi Tada, Milan J Anadkat, Siew Eng Choon, Boni Elewski, Jonathan N Barker

Dermatol Ther (Heidelb)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental triggers of psoriasis: insights from a UK patient-reported cohort (mySkin).
Madeline Kroah-Hartman, John Y W Lee, Niamh Dooley, Wei Ren Tan, Maaike F M Mineur, Jonathan N Barker

Br J Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating CD8 T cells from patients with mild-to-moderate psoriasis are functionally impaired.
Yiqiao Chen, Chiara Tontini, Isabella Tosi, Jonathan N Barker, Paola Di Meglio

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxonomic and functional profiling of skin microbiome in psoriasis.
Hanna Sinkko, Peter Olah, Ying Yang, Guilherme Maia, Mauricio Barrientos-Somarribas, Jonathan Barker

Br J Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Delphi consensus on treatment goals for generalized pustular psoriasis.
Jonathan N Barker, Emmylou Casanova, Siew Eng Choon, Peter Foley, Hideki Fujita

Br J Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions.
Kenneth B Gordon, Yayoi Tada, Milan J Anadkat, Siew Eng Choon, Boni Elewski, Jonathan N Barker

Dermatol Ther (Heidelb)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.
Nick Dand, Philip E Stuart, John Bowes, David Ellinghaus, Joanne Nititham, Jonathan N Barker

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-1 signaling enrichment in inflammatory skin disease loci with higher-risk allele frequencies in African ancestry.
Lam Tsoi, Yumeng Dong, Matthew Patrick, Mrinal Sarkar, Haihan Zhang, Jonathan Barker

Res Sq· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis